News|Articles|May 9, 2024
Pharmacogenomics: Sticking to the Evidence Base
Author(s)John J. Miller, MD
Pharmacogenomics at the 2024 APA Annual Meeting.
Advertisement
CONFERENCE REPORTER
Psychiatric Times Editor-in-Chief, John. J. Miller, MD, sat down with us at the 2024 American Psychiatric Association Annual Meeting to discuss pharmacogenomics, a topic he is very passionate about.
Dr Miller is Medical Director, Brain Health, Exeter, New Hampshire; Editor in Chief, Psychiatric Times; Staff Psychiatrist, Seacoast Mental Health Center, Exeter; Consulting Psychiatrist, Insight Meditation Society, Barre, Massachusetts.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
DT120 (Lysergide) Shows Rapid, Lasting Relief for Generalized Anxiety in Phase 3 Trial
2
Interdisciplinary Consensus Guidelines on Stuttering (Childhood-Onset Fluency Disorder): Addressing Issues in Diagnosis, Treatment, and Unmet Needs
3
Phase 4 Trial of Viloxazine ER Shows Real-World Gains for ADHD With Comorbid Depression, Anxiety
4
Brain Trust: Carl Salzman, MD, on Benzodiazepine Mindful Prescribing, Misuse, and Dependence
5